The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs, favoring more effective, human-relevant ...

US FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs: Maryland Tuesday, April 15, 2025, 14:00 Hrs [IST] The US Food and Drug Adm ...

The Environmental Protection Agency is reinstating a Trump-era initiative to eliminate animal testing, following a decision ...

Cruelty Free International welcomes major shift towards humane, modern approaches to drug development and testing ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

In a landmark shift, the US Food and Drug Administration (FDA) has announced a transformative initiative to advance public health by replacing animal testing in drug development—including monoclonal ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

Humane World for Animals and Humane World Action Fund Applaud FDA’s Historic Move to Phase Out Animal Testing for Biologics and Drugs ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...